| Pharmaceutical Information |
| Drug Name |
Loxapine succinate |
| Drug ID |
BADD_D01327 |
| Description |
An antipsychotic agent used in schizophrenia. [PubChem] |
| Indications and Usage |
For the management of the manifestations of psychotic disorders such as schizophrenia |
| Marketing Status |
approved |
| ATC Code |
N05AH01 |
| DrugBank ID |
DB00408
|
| KEGG ID |
D00794
|
| MeSH ID |
D008152
|
| PubChem ID |
71399
|
| TTD Drug ID |
D0U5OE
|
| NDC Product Code |
64330-112; 53296-0017 |
| UNII |
X59SG0MRYU
|
| Synonyms |
Loxapine | 2-Chloro-11-(4-methyl-1-piperazinyl)-dibenz(b,f)(1,4)oxazepine | Oxilapine | Cloxazepine | Loxapine Hydrochloride | Hydrochloride, Loxapine | Loxitane | Loxapine Succinate | Succinate, Loxapine | Loxapinsuccinate | Loxipine Succinate | Loxipine Maleate | Maleate, Loxipine | CL-71,563 | CL 71,563 | CL71,563 | Loxapine Monohydrochloride |
|
| Chemical Information |
| Molecular Formula |
C22H24ClN3O5 |
| CAS Registry Number |
27833-64-3 |
| SMILES |
CN1CCN(CC1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl.C(CC(=O)O)C(=O)O |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
